Medicare Copays for New Alzheimer's Drug Could Reach $11,500

Medicare Copays for New Alzheimer's Drug Could Reach $11,500

Newsmax

Published

A new $56,000-a-year Alzheimer's drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Wednesday.The drug, called Aduhelm, was approved by the...

Full Article